Print Services: Subscribe | Home Delivery Web: Mobile Edition |

 
Site Web Search powered by YAHOO!SEARCH
 
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Perrigo Co (NQ: PRGO)
113.14 USD  UNCHANGED
Last Price  /  Updated: 8:10 PM EDT, Jun 5, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Perrigo Co
 
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
June 17, 2013
- Expands Perrigo's Rx extended topical portfolio to include ophthalmic sterile ointment and solution products with the addition of nine ANDAs Read More
from PR Newswire
NYSE Euronext Welcomes Leading Global Healthcare Supplier, Perrigo Company, to the New York Stock Exchange
June 06, 2013
from Business Wire News Releases
New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
June 06, 2013
from PR Newswire
Netflix, Inc. to Join the NASDAQ-100 Index Beginning June 6, 2013
May 30, 2013
from GlobeNewswire News Releases
Perrigo Confirms Patent Challenge For Generic Version Of Axiron® Topical Solution
May 29, 2013
from PR Newswire
Perrigo Announces FDA Final Approval For Generic Equivalent To Sanctura XR®
May 29, 2013
from PR Newswire
Perrigo To Transfer Common Stock Listing To NYSE
May 23, 2013
from PR Newswire
Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
May 13, 2013
from PR Newswire
Perrigo Reports Record Revenue and Adjusted Earnings
May 07, 2013
- Fiscal third quarter net sales increased 18% year over year to a record $920 million. Read More
from PR Newswire
Perrigo Company Announces Quarterly Dividend
May 02, 2013
from PR Newswire
Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
April 23, 2013
from PR Newswire
Perrigo Acquisition Of Velcera, Inc. -- Known For Its PetArmor® Franchise Of Flea And Tick Treatments -- Closes Today
April 01, 2013
from PR Newswire
Perrigo Company Closes Acquisition Of Companion Animal Health Company, Velcera, Inc.
April 01, 2013
from PR Newswire
The Pomerantz Firm, Glancy Binkow & Goldberg LLP, and Robbins Geller Rudman & Dowd LLP announce the Notice of Proposed Settlement of the In re: Perrigo Company Securities Litigation
March 22, 2013
from PR Newswire
Drug Companies Grow Through Acquisitions
March 20, 2013
The ShinesRooms.com Provides Stock Research on Perrigo Co. and Prestige Brands Holdings Inc. Read More
from Marketwired News Releases
Perrigo to Begin Shipments of Guaifenesin Extended-Release 600mg Tablets, the First Store Brand Equivalents to Mucinex® 600mg Extended Release Tablets
March 18, 2013
from PR Newswire
Perrigo Company To Present At The Barclays Global Healthcare Conference
March 11, 2013
from PR Newswire
Perrigo Company To Present At The RBC Global Healthcare Conference
February 25, 2013
from PR Newswire
Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
February 19, 2013
from PR Newswire
Free Research Report on Perrigo Co., Garmin Ltd., Calumet Specialty Products Partners, L.P., Trimble Navigation Ltd. and Huntsman Corp.
February 13, 2013
from Marketwired News Releases
Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
February 12, 2013
from PR Newswire
Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
February 11, 2013
- Expands Perrigo's international presence while further enhancing its manufacturing and research and development capabilities Read More
from PR Newswire
Perrigo Confirms FDA Approval For Testosterone Gel 1%
February 05, 2013
from PR Newswire
Velcera, Inc. Signs Definitive Agreement to be Acquired by Perrigo Company for $160 Million in Cash
February 01, 2013
from Business Wire News Releases
The Real Story Behind ETN, KMP, TROW and PRGO
February 01, 2013
from Marketwired News Releases
Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
February 01, 2013
from PR Newswire
Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
February 01, 2013
- Accelerates Perrigo's store brand strategy in the increasingly important OTC adjacent category of retail pet healthcare Read More
from PR Newswire
Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
February 01, 2013
- Fiscal second quarter adjusted net income increased 14% to a record $128 million, or $1.36 per diluted share. Read More
from PR Newswire
Perrigo Company Announces Quarterly Dividend
January 31, 2013
from PR Newswire
Perrigo Nutritionals Unveils New Packaging Innovation in Their Continued Effort to Advance Quality, Affordable Healthcare
January 25, 2013
New, Innovative SmarTub™ Infant Formula Package for Moms, Same Quality Nutrition for Babies Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Copyright 2008 San Jose Mercury News
Help | Site Map | Advertise | Newsletters | Home Delivery | Copyright | About MediaNews Group | RSS | Ethics Policy

Privacy Policy  |   Site Map